Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1994 2
1997 1
1999 1
2001 1
2002 2
2003 6
2004 8
2005 8
2006 6
2007 11
2008 17
2009 12
2010 18
2011 6
2012 1
2013 6
2014 4
2015 4
2016 8
2017 3
2018 6
2019 5
2020 12
2021 8
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

150 results
Results by year
Filters applied: . Clear all
Page 1
EDITORIAL COMMENT.
Karzai F, Couvillon A, Dahut WL. Karzai F, et al. Among authors: dahut wl. Urology. 2021 Oct;156:102-103. doi: 10.1016/j.urology.2021.05.081. Urology. 2021. PMID: 34758550 No abstract available.
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors.
Apolo AB, Nadal R, Girardi DM, Niglio SA, Ley L, Cordes LM, Steinberg SM, Sierra Ortiz O, Cadena J, Diaz C, Mallek M, Davarpanah NN, Costello R, Trepel JB, Lee MJ, Merino MJ, Bagheri MH, Monk P, Figg WD, Gulley JL, Agarwal PK, Valera V, Chalfin HJ, Jones J, Streicher H, Wright JJ, Ning YM, Parnes HL, Dahut WL, Bottaro DP, Lara PN Jr, Saraiya B, Pal SK, Stein MN, Mortazavi A. Apolo AB, et al. Among authors: dahut wl. J Clin Oncol. 2020 Nov 1;38(31):3672-3684. doi: 10.1200/JCO.20.01652. Epub 2020 Sep 11. J Clin Oncol. 2020. PMID: 32915679 Free PMC article. Clinical Trial.
A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening.
Beshiri ML, Tice CM, Tran C, Nguyen HM, Sowalsky AG, Agarwal S, Jansson KH, Yang Q, McGowen KM, Yin J, Alilin AN, Karzai FH, Dahut WL, Corey E, Kelly K. Beshiri ML, et al. Among authors: dahut wl. Clin Cancer Res. 2018 Sep 1;24(17):4332-4345. doi: 10.1158/1078-0432.CCR-18-0409. Epub 2018 May 10. Clin Cancer Res. 2018. PMID: 29748182 Free PMC article.
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer.
Madan RA, Karzai FH, Al Harthy M, Petrylak DP, Kim JW, Arlen PM, Rosner I, Theoret MR, Cordes L, Bilusic M, Peer CJ, Dawson NA, Couvillon A, Hankin A, Williams M, Chun G, Owens H, Marte JL, Lee MJ, Tomita Y, Yuno A, Trepel JB, Lee S, Steinberg SM, Gulley JL, Figg WD, Dahut WL. Madan RA, et al. Among authors: dahut wl. BJU Int. 2021 Apr;127(4):435-444. doi: 10.1111/bju.15227. Epub 2020 Oct 23. BJU Int. 2021. PMID: 32969563 Free PMC article. Clinical Trial.
Angiogenesis inhibitors in the treatment of prostate cancer.
Adesunloye BA, Karzai FH, Dahut WL. Adesunloye BA, et al. Among authors: dahut wl. Chem Immunol Allergy. 2014;99:197-215. doi: 10.1159/000353255. Epub 2013 Oct 17. Chem Immunol Allergy. 2014. PMID: 24217611 Review.
VEGF inhibitors and prostate cancer therapy.
Aragon-Ching JB, Dahut WL. Aragon-Ching JB, et al. Among authors: dahut wl. Curr Mol Pharmacol. 2009 Jun;2(2):161-8. doi: 10.2174/1874467210902020161. Curr Mol Pharmacol. 2009. PMID: 19617926 Free PMC article. Review.
150 results